Skip to main content

The Radiation Safety Committee Explained

Troy Zhou, PhD, DABR, DABSNM By Troy Zhou, PhD, DABR, DABSNM
March 3, 2026 • 16 min read
#Radiation Safety #ALARA #NRC #Risk Management #Occupational Exposure

The Radiation Safety Committee (RSC) is the governance body that holds a medical facility's radioactive-material program accountable — the structure that turns radiation safety from one person's job into an institutional commitment. It brings authorized users, the radiation safety officer, nursing, and management to one table to oversee dose, ALARA, new uses, and program changes.

For licensees authorized for multiple types of medical use of byproduct material, an RSC is typically a condition of the license. But even where a formal committee is not strictly required, the underlying obligation — documented oversight, management commitment, and ALARA governance — does not go away.17

Introduction

Radiation safety in a hospital is not self-executing. Someone has to decide whether a new authorized user is qualified, whether a proposed Lu-177 therapy service fits the license, whether last quarter's finger doses are drifting upward, and whether the program has the budget and authority to do its job. In a single-physician clinic that "someone" may be the radiation safety officer alone. In a larger institution with imaging, therapy, and research uses, concentrating all of that in one person is neither realistic nor compliant. That is the gap the Radiation Safety Committee fills.17

The RSC is fundamentally a governance and accountability mechanism. The NRC's framework places the day-to-day program in the hands of the RSO, but it requires that management formally commit to supporting that role, and — for more complex programs — that a committee provide standing oversight.1 Done well, the committee is where problems surface early and where management ownership of radiation safety becomes visible and documented.

This guide explains what the RSC is, when it is required, who sits on it, what it reviews, and how it supports ALARA — plus the regulatory backbone and the common failure modes. DRPS helps facilities stand up and run effective committees through its radiation safety officer and radioactive material license support services across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Topic Explanation

What the RSC is — and is not

The RSC is an oversight body, not an operations team. It does not run surveys, calibrate dose calibrators, or perform wipe tests — that is the RSO's program. The committee reviews how that program is performing, sets policy, approves who may use radioactive material and for what, and ensures management gives the program the authority and resources it needs.17

The relationship between the key roles is worth stating plainly:

  • Management holds the license and bears ultimate responsibility. It must provide a written commitment of authority and resources to the RSO.1
  • The Radiation Safety Officer (RSO) is the individual responsible for day-to-day implementation of the radiation protection program; see our deep dive on the radiation safety officer role.
  • The Radiation Safety Committee (RSC) is the collective oversight body that reviews the program, approves new users and uses, and ensures management support — the RSO typically reports to and advises it.

When is an RSC required?

A formal RSC is generally required, as a license condition, when a licensee is authorized for two or more different types of medical use under 10 CFR Part 35 — for example, combining diagnostic imaging with therapy, or running multiple therapy modalities (such as manual brachytherapy plus radiopharmaceutical therapy).17 A licensee authorized for only a single type of use may not be required to maintain a committee, but still must have a qualified RSO, a radiation protection program, documented management commitment, and ALARA oversight.13

This is a frequent point of confusion. The absence of a mandatory committee does not mean the absence of governance. Many smaller facilities convene a committee voluntarily because it sharpens accountability and inspection readiness even when not strictly required.

Key Technical Principles

Required membership

NRC guidance is specific about who must sit on the committee. The membership must include:17

Member Why they are required
An authorized user for each type of use on the license Brings clinical and modality-specific expertise for every authorized use (imaging, therapy, etc.)
The Radiation Safety Officer Presents program performance, dose data, incidents, and recommendations
A representative of the nursing service Connects radiation safety to patient-care areas, ward management, and inpatient therapy
A representative of management (not an AU or the RSO) Provides institutional authority, resources, and accountability
Other members as appropriate (e.g., medical physicist, radiochemist, administrator) Optional but common; adds technical depth

The management representative requirement is deliberate: it forces an accountable institutional decision-maker — not just technical staff — to sit at the table and own the program. The optional medical physicist seat is where DRPS frequently contributes, providing independent technical review of dose data, shielding, and equipment changes.

Meetings, quorum, and minutes

NRC model procedures in NUREG-1556 commonly call for the committee to meet at least quarterly, with a defined quorum — frequently at least half of the membership, including the RSO and a management representative.7 The exact cadence and quorum are fixed in the licensee's own procedures and license conditions, but the principles are consistent: meet regularly, have enough of the right people present to make decisions, and document everything.

Minutes are not a formality. They are part of the license record, they are reviewed during NRC or Agreement State inspections, and they are the evidence that oversight actually happened. Minutes should capture attendance, dose-trend review, decisions on new users and uses, incident discussion, action items, and follow-up on prior items. For how this plays out under examination, see our guide to preparing for an NRC inspection.

Supporting ALARA: investigation levels

One of the committee's core technical functions is reviewing dose data against ALARA investigation levels. The regulatory ceilings come from 10 CFR Part 20: the occupational total effective dose equivalent (TEDE) limit is 5 rem (0.05 Sv) per year, and the dose limit for an individual member of the public is 0.1 rem (1 mSv) per year, with no more than 0.002 rem (0.02 mSv) in any one hour in an unrestricted area.456

ALARA programs do not wait until someone approaches those limits. NRC ALARA guidance establishes lower investigation levels — commonly a Level I and a higher Level II — expressed as fractions of the applicable limit, that trigger review and action well before a regulatory limit is in play.8 Using commonly applied fractions of 10% (Level I) and 30% (Level II) of the quarterly occupational limit:

The quarterly fraction of the annual occupational TEDE limit is:

The Level I and Level II investigation levels for deep-dose equivalent are then:

When a worker's dose exceeds Level I, the RSO reviews the cause; when it exceeds Level II, the committee reviews it and documents corrective action.8 This is exactly the kind of trend data the RSC exists to govern — catching a drift in interventional or therapy staff dose long before it becomes a violation. For the monitoring program that generates these numbers, see occupational exposure monitoring and the building an ALARA program guide.

Clinical Impact

The committee's decisions shape what radioactive-material services a facility can safely offer and how well it withstands scrutiny. Its impact is felt in several concrete ways:

  • Service expansion. When a department wants to launch a theranostics program, add a new PET tracer, or bring on a new authorized user, the RSC is the body that evaluates qualifications, training, facilities, and license fit before the service goes live — preventing operating outside the license.17
  • Early problem detection. Standing dose-trend and incident review catches problems — a contamination trend, rising extremity doses, a near-miss in therapy — while they are still correctable.8
  • Medical event response. When a medical event occurs (a dose or administration outside prescribed parameters), the committee reviews the root cause and corrective actions; reporting obligations are governed by 10 CFR 35.3045. See medical event reporting under 10 CFR 35.3045.
  • Inspection readiness. A committee with current membership, regular meetings, and complete minutes is one of the clearest signals to an inspector that a program is healthy. A committee that exists on paper but has not met in a year is a red flag — and a common citation theme, as discussed in common radiation safety violations.

Practical Optimization Tips

1. Keep membership current and quorate

License conditions name the membership categories, not individuals — but the committee must actually have a seated authorized user for each type of use, plus the RSO, nursing, and management. When an AU leaves or a new use is added, update the roster promptly and amend the license if required.17

2. Run the meeting from a standing agenda

A repeatable agenda keeps oversight from becoming ad hoc. Recommended standing items:

  • Review and approval of prior minutes and open action items
  • Occupational and public dose trends vs. ALARA investigation levels
  • New authorized-user and new-use requests
  • Incidents, near-misses, and any medical events
  • Audit, survey, and inspection findings
  • License amendments, equipment, and facility changes
  • Annual program review (at least once per year)

3. Make management presence non-negotiable

The management representative is the point of the exercise. If that seat is chronically empty, the committee loses its authority-and-resources function and the program drifts. Treat management attendance as a quorum requirement, not an optional courtesy.1

4. Connect the committee to the annual review

10 CFR Part 20 requires periodic review of the radiation protection program and its content. Use the committee to conduct or ratify the annual ALARA and program review so that the regulatory review and the governance review are the same documented act.34

5. Document decisions, not just discussion

Minutes that say "dose data reviewed" prove nothing. Record what was reviewed, what was decided, who is responsible, and the due date — then track closure at the next meeting.7

Common pitfalls

  • A paper committee that is chartered but does not meet, or meets without a quorum.
  • Missing an AU category when the license adds a new type of use.
  • No management representative actually attending.
  • Minutes without decisions or action tracking.
  • Reviewing doses only against regulatory limits, never against the lower ALARA investigation levels that catch drift early.8
  • Treating the committee as separate from the annual program review instead of integrating them.

Regulatory Considerations

The RSC sits inside the NRC (or Agreement State) framework for medical use of byproduct material, and its authority flows from the license itself.

  • 10 CFR 35.24 — Authority and responsibilities for the radiation protection program. Establishes management's commitment to the RSO, the RSO's (and associate RSO's) authority, and the framework under which committee oversight operates.1
  • 10 CFR 35.26 — Radiation protection program changes. Governs which program changes a licensee may make without prior NRC approval and what must be documented — frequently a committee decision point.2
  • 10 CFR 35.3045 — Report and notification of a medical event. Defines medical events and the reporting timeline, a recurring item of committee review.9
  • 10 CFR Part 20 — Standards for Protection Against Radiation. Sets the dose limits and the requirement for a radiation protection program and its periodic review, including ALARA.3456
  • NUREG-1556, Volume 9, Revision 3. The NRC's consolidated guidance for medical-use licenses, including model RSC procedures, membership, and meeting expectations.7
  • NRC Regulatory Guide 8.10. Operating philosophy for keeping occupational exposures ALARA, the basis for investigation levels.8

Agreement States administer parallel programs. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States with their own equivalent rules, while Washington DC and Delaware are regulated directly by the NRC for byproduct material. A licensee must confirm which authority issues its license and exactly what RSC composition, meeting frequency, and recordkeeping its license conditions impose. The international optimization principle behind ALARA — justification, optimization, and dose limitation — is articulated in ICRP Publication 103.10 For the licensing big picture, see our NRC radioactive material license guide.

Frequently Asked Questions (FAQs)

What is a Radiation Safety Committee?

A Radiation Safety Committee (RSC) is the institutional governance body that oversees a medical facility's use of radioactive material under its NRC or Agreement State license. It brings together authorized users, the RSO, a nursing representative, and a management representative to review the radiation protection program, monitor doses and ALARA performance, approve new users and uses, and ensure the program has the authority and resources it needs.

When is a Radiation Safety Committee required?

An RSC is generally required as a license condition when a licensee is authorized for two or more different types of medical use of byproduct material under 10 CFR Part 35 — for example, both imaging and therapy, or multiple therapy modalities. Small single-use licensees may not be required to have a formal committee, but they still must have an RSO and a radiation protection program.

Who must be on the Radiation Safety Committee?

Per NRC guidance, the committee must include an authorized user for each type of use permitted by the license, the RSO, a representative of the nursing service, and a representative of management who is neither an authorized user nor the RSO. The licensee may add other members, such as a medical physicist, as appropriate.

How often does the Radiation Safety Committee meet?

NRC model procedures in NUREG-1556 commonly call for the committee to meet at least quarterly, with a defined quorum (often at least half of the membership including the RSO and a management representative). The exact frequency and quorum are set in the licensee's own procedures and license conditions.

What is the difference between the RSO and the RSC?

The RSO is the individual responsible for the day-to-day implementation of the radiation protection program. The RSC is the oversight body that reviews the program, sets policy, approves new users and uses, and ensures management support. The RSO typically reports to and advises the committee.

What does the Radiation Safety Committee actually review?

Standing business usually includes occupational and public dose trends against ALARA investigation levels, new authorized-user and new-use requests, incidents and any medical events, audit and inspection findings, license amendments, equipment and facility changes, and the annual program review. The committee documents its decisions in minutes that become part of the license record.

Can a small clinic skip the Radiation Safety Committee?

A clinic authorized for only one type of medical use may not be required to maintain a formal RSC, but it cannot skip radiation safety governance: it still needs a qualified RSO, a radiation protection program, management commitment, and ALARA oversight. Many facilities not strictly required to have a committee still convene one because it strengthens accountability and inspection readiness.

Key Takeaways

  • The RSC is governance, not operations — it oversees the program the RSO runs.17
  • A formal committee is generally required for multi-use licensees (e.g., imaging plus therapy); single-use licensees still need an RSO and a documented program.17
  • Membership is specified: an authorized user for each type of use, the RSO, a nursing representative, and a management representative who is neither.17
  • Meet at least quarterly, with a quorum, and document decisions — minutes are part of the license record and a focus of inspection.7
  • Review doses against ALARA investigation levels, not just the 5 rem/yr occupational and 1 mSv/yr public limits, to catch drift early.48
  • Management presence is the point — it is what converts radiation safety into an institutional commitment.1

Conclusion

The Radiation Safety Committee is the institutional backbone of a medical radioactive-material program. It is where a hospital decides who may use radioactive material and for what, where dose trends are caught before they become violations, where medical events are dissected for root cause, and where management's commitment to safety is made visible and documented. The regulatory framework — 10 CFR 35.24, Part 20, and NUREG-1556 — defines the committee's membership and mandate, but the value comes from running it as a real oversight body, not a paper formality.147

A facility that treats its committee seriously — current membership, regular quorate meetings, dose review against ALARA investigation levels, and minutes that record decisions and track them to closure — has a program that protects workers and patients and that holds up under inspection. A committee that exists only on the org chart protects no one.

How DRPS Can Help

Diagnostic Radiation Physics Services helps facilities establish and strengthen Radiation Safety Committees: drafting committee charters and standing agendas aligned with NUREG-1556 model procedures, serving as the medical-physicist member, providing independent review of dose trends and ALARA investigation levels, supporting new-use and new-AU evaluations, and preparing committees for NRC and Agreement State inspections. This is delivered through our radiation safety officer, radioactive material license support, radiation safety training, and medical physicist consulting services.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A strong committee does not just satisfy a license condition. It makes radiation safety an institutional habit — owned by management, advised by the RSO, and reviewed by everyone whose work it touches.

Related Resources

References

  1. U.S. Nuclear Regulatory Commission. 10 CFR 35.24: Authority and responsibilities for the radiation protection program. nrc.gov
  2. U.S. Nuclear Regulatory Commission. 10 CFR 35.26: Radiation protection program changes. nrc.gov
  3. U.S. Nuclear Regulatory Commission. 10 CFR 20.1101: Radiation protection programs. nrc.gov
  4. U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov
  5. U.S. Nuclear Regulatory Commission. 10 CFR 20.1201: Occupational dose limits for adults. nrc.gov
  6. U.S. Nuclear Regulatory Commission. 10 CFR 20.1301: Dose limits for individual members of the public. nrc.gov
  7. U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 9, Revision 3: Consolidated Guidance About Materials Licenses — Program-Specific Guidance About Medical Use Licenses. 2019. nrc.gov
  8. U.S. Nuclear Regulatory Commission. Regulatory Guide 8.10: Operating Philosophy for Maintaining Occupational Radiation Exposures As Low As Is Reasonably Achievable. nrc.gov
  9. U.S. Nuclear Regulatory Commission. 10 CFR 35.3045: Report and notification of a medical event. nrc.gov
  10. International Commission on Radiological Protection. ICRP Publication 103: The 2007 Recommendations of the International Commission on Radiological Protection. Annals of the ICRP. 2007;37(2-4). icrp.org